Sarepta Therapeutics
SRPT
SRPT
179 hedge funds and large institutions have $1.21B invested in Sarepta Therapeutics in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 44 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2.09% more ownership
Funds ownership: 72.29% → 74.38% (+2.1%)
1% more funds holding
Funds holding: 177 → 179 (+2)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
179
Holding in Top 10
2
Calls
$108M
Puts
$54.9M
Top Buyers
| 1 | +$153M | |
| 2 | +$45.9M | |
| 3 | +$40M | |
| 4 |
O
OrbiMed
New York
|
+$31.2M |
| 5 |
PC
PointState Capital
New York
|
+$18.9M |
Top Sellers
| 1 | -$55.3M | |
| 2 | -$29.6M | |
| 3 | -$27.7M | |
| 4 |
JG
Jefferies Group
New York
|
-$23M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.7M |